Latest Management of cancer Stories
SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.
Survey results published today, by a Tampa Bay medical device manufacturer, BioDerm, reveal a surprising connection between music and patient’s perceptions of the side effects of prostate cancer
LOS ANGELES, May 7, 2014 /PRNewswire/ -- Skin doctor, Dr.
Hope Summit and New Scientific Grant Applications Kick Off Lung Cancer Hope Month WASHINGTON, May 6, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit,
New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/
Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc.
Cianna Medical: Early-stage breast cancer treatment enables more women to opt for partial breast radiation. Aliso Viejo, CA (PRWEB) May 01, 2014
Researchers at the University of California, San Diego School of Medicine report that a protein called beta-catenin plays a critical, and previously unappreciated, role in promoting recovery of stricken hematopoietic stem cells after radiation exposure.
CAMBRIDGE, Mass., May 1, 2014 /PRNewswire-USNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.